Health Trials

Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy)

1

Review clinical trials related to Sub-study 2 Head and Neck Squamous Cell Carcinoma (Volrustomig Monotherapy). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors

eVOLVE-02 study will evaluate the efficacy and safety of volrustomig as monotherapy or in combination with anti-cancer agents in participants with advanced/metastatic solid tumors.

Participants needed: 257
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: AstraZenecaUpdated: Sep 11, 2026Locations: 98
Eligibility criteria

Age ≥18 at the time of signing the ICF. [+7]

Spinal cord compression. [+19]

Read more